Clinical Trials Browser

Phase 1/2 × Glioblastoma × Mercaptopurine × Clear all

NCT06279767 2024-02-28

Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma

Phase 1/2 Unknown

Glioblastoma, Neoplasms